Atlanta Braves Holdings Insider Plans $1.8M Series C Share Sale

Rhea-AI Filing Summary

Atlanta Braves Holdings, Inc. (Ticker: BATRK) has filed a Form 144 indicating an intention to sell restricted securities under Rule 144.

The notice covers 40,000 shares of the company’s Series C common stock with an aggregate market value of $1.76 million, to be brokered through UBS Financial Services on or about 18 June 2025 on the NASDAQ market. Outstanding shares of the Series C class are reported at 51,297,110, making the proposed sale roughly 0.08 % of that class.

The filing also discloses that Derek Schiller—listed in the “Securities Sold During the Past 3 Months” table—sold 72,505 shares of the same class on 11 June 2025 for $3.12 million. Together with the new notice, insider sales over the last quarter total 112,505 shares valued at approximately $4.88 million, or about 0.22 % of the outstanding Series C float.

The shares to be sold were acquired via option exercise on 18 June 2025 and paid for in cash, as disclosed under “Nature of Acquisition Transaction.” The filer represents that no undisclosed material adverse information is known, in line with Rule 144 requirements.

Key Takeaways:

• Form 144 signals a potential insider sale but is not, by itself, a commitment to sell.
• The size of the planned sale is small relative to total shares outstanding, suggesting limited direct dilution or market impact.
• Investors may nonetheless monitor continued insider activity for sentiment signals, especially given the recent prior sale by the same insider.

Insights

Securities Analyst

TL;DR: Insider plans to sell 40k BATRK Series C shares (~$1.8 m), modest vs. float; sentiment-watch more than balance-sheet event.

The Form 144 filing shows a routine notice of proposed insider sales. The 40,000-share block equates to ~0.08 % of the Series C class—too small to affect liquidity or capital structure. Combined with the prior 72,505-share sale, insider disposition over the last quarter remains below 0.25 % of shares outstanding. Because the transaction stems from option exercise, it likely follows a pre-arranged plan or compensation cycle. From a valuation perspective, the sale neither injects cash into the company nor alters fundamentals; it merely signals insider sentiment. The absence of undisclosed adverse information attestation is boiler-plate. Overall, I assess the development as neutral with minimal price impact, though continued monitoring of insider trends is prudent.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Series C Common Stock	UBS Financial Services Inc. 11 Madison Avenue 4th Floor New York NY 10010	40000	1760000.00	51297110	06/18/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Series C Common Stock	06/18/2025	Exercise of Stock Options	Issuer			40000	06/18/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Derek Schiller 755 BATTERY AVENUE SE ATLANTA GA 30339	Series C Common Stock	06/11/2025	72505	3117767.01

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many BATRK Series C shares are insiders planning to sell under this Form 144?

The notice covers 40,000 Series C common shares.

What is the dollar value of the proposed BATRK insider sale?

The aggregate market value is $1.76 million.

When is the anticipated sale date for the 40,000 BATRK shares?

The approximate sale date disclosed is 18 June 2025.

How many BATRK shares did the same insider sell in the past three months?

The insider sold 72,505 shares on 11 June 2025 for $3.12 million.

What percentage of the Series C class does the 40,000-share sale represent?

It represents roughly 0.08 % of the 51,297,110 Series C shares outstanding.

Which broker is executing the planned BATRK share sale?

The broker listed is UBS Financial Services Inc.